After its latest pipeline clear-out, Merck KGaA is no longer pursuing any clinical-stage cancer candidates...
Merck
German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical...
Merck is paying $9.2 billion for Cidara Therapeutics and its phase 3 antiviral that is...
Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing...
Patients with polycythemia vera (PV), a rare cancer characterized by overabundant red blood cells, have...
Merck KGaA has become the latest Big Pharma to tap the drug discovery expertise of...
Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million...
Less than two years after breaking ground on a ballyhooed 1 billion pound sterling ($1.31...
Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could...
As Merck & Co. rolls out a widespread cost-cutting initiative, the pharma is dropping an...